These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 11190459)
1. [Microabluminuria in arterial hypertension. Measurement, variables, interpretation, recommendations]. Hornych A; Marre M; Mimran A; Chaignon M; Asmar R; Fauvel JP; Arch Mal Coeur Vaiss; 2000 Nov; 93(11):1304-8. PubMed ID: 11190459 [TBL] [Abstract][Full Text] [Related]
2. Microalbuminuria as an early marker for cardiovascular disease. de Zeeuw D; Parving HH; Henning RH J Am Soc Nephrol; 2006 Aug; 17(8):2100-5. PubMed ID: 16825327 [TBL] [Abstract][Full Text] [Related]
4. Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients. Kato T; Horio T; Tomiyama M; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y Nephrol Dial Transplant; 2007 Mar; 22(3):911-6. PubMed ID: 17142262 [TBL] [Abstract][Full Text] [Related]
5. [Microalbuminuria in arterial hypertension]. Pérez-Blanco FJ; Azcón González De Aguilar P; Miras Parra FJ; Morales Camacho L An Med Interna; 1998 Jul; 15(7):381-3. PubMed ID: 9710992 [TBL] [Abstract][Full Text] [Related]
6. The importance of microalbuminuria as a cardiovascular risk indicator: A review. Diercks GF; van Boven AJ; Hillege JL; de Jong PE; Rouleau JL; van Gilst WH Can J Cardiol; 2002 May; 18(5):525-35. PubMed ID: 12032579 [TBL] [Abstract][Full Text] [Related]
7. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria. Mulè G; Castiglia A; Cusumano C; Scaduto E; Geraci G; Altieri D; Di Natale E; Cacciatore O; Cerasola G; Cottone S Adv Exp Med Biol; 2017; 956():279-306. PubMed ID: 27873229 [TBL] [Abstract][Full Text] [Related]
8. Microalbuminuria: do we need a new threshold? Zamora CR; Cubeddu LX J Hum Hypertens; 2009 Feb; 23(2):146-9. PubMed ID: 18784737 [TBL] [Abstract][Full Text] [Related]
10. Twelve shifting paradigms in diabetic renal disease and hypertension. Mogensen CE Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S2-9. PubMed ID: 18947897 [TBL] [Abstract][Full Text] [Related]
11. Urinary albumin and cardiovascular profile in the middle-aged population. Cirillo M; Lombardi C; Bilancio G; Chiricone D; Stellato D; De Santo NG Semin Nephrol; 2005 Nov; 25(6):367-71. PubMed ID: 16298257 [TBL] [Abstract][Full Text] [Related]
12. Chronic kidney disease and global cardiovascular risk in essential hypertension. Segura J; Campo C; Ruilope LM Minerva Med; 2004 Oct; 95(5):375-83. PubMed ID: 15467513 [TBL] [Abstract][Full Text] [Related]
13. Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes. Donnelly R; Yeung JM; Manning G J Hypertens Suppl; 2003 Mar; 21(1):S7-12. PubMed ID: 12769161 [TBL] [Abstract][Full Text] [Related]